Featured Story
Intel and telcos left in virtual RAN limbo by rise of AI RAN
A multitude of general-purpose and specialist silicon options now confronts the world's 5G community, while Intel's future in telecom remains uncertain.
Agreement with Boston Scientific to develop mobile health-monitoring apps
March 14, 2012
NEWBURY, U.K. -- Vodafone Global Enterprise – the business within Vodafone which manages the communications needs of its largest multinational customers – today announced an agreement with Boston Scientific Corporation, a global leader in the design of medical devices, to develop mobile health monitoring solutions that are set to transform healthcare by providing doctors with real-time information about patients' cardiac health and certain vital signs remotely.
Remote healthcare monitoring systems, powered by Vodafone's global world-leading* "machine-to-machine" (M2M) technology, will allow patients to use mobile devices to send health information to their doctor without having to leave their home. This reduces pressure on hospital outpatient and inpatient services and significantly increases the speed with which doctors and consultants can respond to early signs of deterioration in their patients' cardiac condition.
Vodafone Group plc (NYSE: VOD)
You May Also Like